Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
273M
-
Shares change
-
+487K
-
Total reported value, excl. options
-
$2.65B
-
Value change
-
+$16.3M
-
Put/Call ratio
-
0.58
-
Number of buys
-
115
-
Number of sells
-
-78
-
Price
-
$9.74
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q4 2019
255 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q4 2019.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 273M shares
of 309M outstanding shares and own 88.26% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (25.2M shares), PERCEPTIVE ADVISORS LLC (25.1M shares), VANGUARD GROUP INC (23.8M shares), BlackRock Inc. (20.9M shares), MORGAN STANLEY (12.4M shares), Avoro Capital Advisors LLC (11.2M shares), STATE STREET CORP (11M shares), JANUS HENDERSON GROUP PLC (10.8M shares), Palo Alto Investors LP (7.41M shares), and JENNISON ASSOCIATES LLC (7.21M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.